Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein

Clicks: 108
ID: 271972
2011
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #149 of 206 articles by views in genes & development

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 206 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The Yes-associated protein (YAP) is a transcription coactivator that plays a crucial role in organ size control by promoting cell proliferation and inhibiting apoptosis. The Hippo tumor suppressor pathway inhibits YAP through phosphorylation-induced cytoplasmic ...
Reference Key
guan2011genesangiomotin Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Bin Zhao, Li Li, Qing Lu, Lloyd H. Wang, Chen-Ying Liu, Qunying Lei, Kun-Liang Guan;Bin Zhao;Li Li;Qing Lu;Lloyd H. Wang;Chen-Ying Liu;Qunying Lei;Kun-Liang Guan;
Journal genes & development
Year 2011
DOI
10.1101/gad.2000111
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.